Health · 1 sources covering this

Testing service members' testosterone levels is a tricky proposition

NPR's Ailsa Chang talks with Dr. Adriane Fugh-Berman of Georgetown University about the Defense Department's plan to screen service members' testosterone levels and offer supplementation.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

NPRLean L·2h ago
Testing service members' testosterone levels is a tricky proposition
NPR's Ailsa Chang talks with Dr. Adriane Fugh-Berman of Georgetown University about the Defense Department's plan to screen service members' testosterone levels and offer supplementation.
Read at NPR →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/bbb769591c8ec8711385c2b09a7016fa1a3b7b14"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Testing service members' testosterone levels is a tricky proposition"></iframe>

Testing service members' testosterone levels is a tricky proposition

How 1 sources are covering this

Testing service members' testosterone levels is a tricky proposition

More from Health

STAT+: Fresh turmoil roils American Diabetes Association following controversy at conference

Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy

Predicting biotech clinical trials & a new Alzheimer’s drug controversy

STAT+: GOP blocks effort to end Medicare test of AI prior authorization

Reader

Trust & legal

Across the network

How 1 sources are covering this

Testing service members' testosterone levels is a tricky proposition

More from Health

STAT+: Fresh turmoil roils American Diabetes Association following controversy at conference

Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy

Predicting biotech clinical trials &#038; a new Alzheimer&#8217;s drug controversy

STAT+: GOP blocks effort to end Medicare test of AI prior authorization

Reader

Trust & legal

Across the network

Predicting biotech clinical trials & a new Alzheimer’s drug controversy